Publications:

Osimertinib as first-line therapy in advanced NSCLC: a profile of its use.

Drugs & Therapy Perspectives : For Rational Drug Selection And Use

Scott, Lesley J LJ

Publication Date: 2018

Variant appearance in text: HR: L885R

PubMed Link: 30631243

Variant Present in the following documents:

• Main text
• 40267_2018_Article_536.pdf

View BVdb publication page

EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: analysis of LUX-Lung 3 and 6.

British Journal Of Cancer

Wu, Yi-Long YL; Sequist, Lecia V LV; Hu, Cheng-Ping CP; Feng, Jifeng J; Lu, Shun S; Huang, Yunchao Y; Li, Wei W; Hou, Mei M; Schuler, Martin M; Mok, Tony T; Yamamoto, Nobuyuki N; O'Byrne, Kenneth K; Hirsh, Vera V; Gibson, Neil N; Massey, Dan D; Kim, Miyoung M; Yang, James Chih-Hsin JC

Publication Date: 2017-01-17

Variant appearance in text: HR: L885R

PubMed Link: 28006816

Variant Present in the following documents:

• bjc2016420a.pdf

View BVdb publication page